Fresenius Medical Care AG
XMUN:FME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Fresenius Medical Care AG (FME) under the Base Case is 42.27 EUR per share.
Compared with the current market price of 39.59 EUR, the stock appears
Undervalued by 6% .
The intrinsic value is calculated using the DCF method. The model assumes Fresenius Medical Care's net margin rises to 6.5% by 2031, near its six-year high and above last year's 5%. If its margin stayed at its five-year average of 3.9%, the estimate would be about €38. Margins affect only the forecast years; the value of the years after 2031 uses a revenue multiple.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Fresenius Medical Care Does
Fresenius Medical Care AG is one of the world’s main kidney care companies. It treats patients with chronic kidney failure by running dialysis clinics and by providing dialysis treatments in hospitals and care centers. It also sells the equipment, filters, and related supplies needed to deliver dialysis, which makes it both a care provider and a medical products supplier.
- Headquarters
- Germany DE
- Employees
- 123 106
- IPO date
- Oct 2, 1996
Fresenius Medical Care has no economic moat
In much of the U.S., government reimbursement and competition based on care quality, access, and physician referrals leave little evidence that the Fresenius name lets the company charge more. Patients and doctors can choose other dialysis providers, and Fresenius’s scale does not make its services more valuable simply because more people use them.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
Fresenius Medical Care kept its 2026 revenue outlook broadly flat but narrowed its operating-income outlook, citing a more pressured second half and higher inflation headwinds.
Open the earnings call- Stock, next trading day
- +0.5%
Past 12 months
Continue FME Research
Decided on Fresenius Medical Care? Get an email when FME reaches the price you’d buy at. Free with an account.
Other Fresenius Medical Care listings
What is the Intrinsic Value of one FME stock?
The intrinsic value for
Fresenius Medical Care AG (FME) under the Base Case is 42.27 EUR.
Is FME stock undervalued or overvalued?
Compared with the current market price of 39.59 EUR, the stock appears Undervalued by 6% .